Description: Harbin Pharmaceutical Group Co., Ltd. engages in the research, development, manufacture, and trade of pharmaceuticals in China and internationally. The company operates through seven segments: Antibiotics, Small-Molecular Drug Preparations, OTC and Healthcare Products, Modern Chinese Medicines, Biopharmaceuticals, Animal Vaccines, and Medicine Circulations. It offers a series of penicillin and cephalosporin products, as well as intermediates. The company's lead products include Shuang Huanglian freeze-dried injection; Danshen freeze-dried injection; Shuang Huanglian powder for injection; roxithromycin dispersible tablets; belladonna, sulfamethoxazole, and trimerhoprim tablets; pediatric paracetamol, atificial cow-bezoar, and chlorphenamine maleate granules; Shuanghuanglian oral liquid; and ceftriaxone sodium for injection. Its lead products also comprise amoxicillin capsules, cefotiam hydrochloride for injection, panax ginseng extract, cefepime hydrochloride for injection, cefoperazone sodium for injection, and amoxicillin sodium and clavulanate potassium for injection; cefuroxime sodium, ceftazidime, cefotaxime sodium, and ceftriaxone sodium for injections; and ampicillin capsules. In addition, the company offers medical protective and disposable surgical masks, medical disposable protective gowns, and isolation gowns. It offers its products under the Hongyan Yaopin, Guangwei, Renmin Tongtai, Hayao Shengwu, Baohulu, Manshanhong, Hutong, Hayaoliu, Gaizhonggai, Sanchine, Shiyitang, and Hayao brands. The company is based in Harbin, China.
Home Page: www.hayao.com
No. 68, Limin West Fourth Street
Harbin,
150025
China
Phone:
86 451 5187 0077
Officers
| Name | Title |
|---|---|
| Mr. Jun Zhang Li | Chairman of Board of Directors and Gen. Mang. |
| Mr. Zhi Jun Wu | Deputy Gen. Mang. and Director |
| Mr. Xiaodong Meng | Deputy Gen. Mang., Sec. of the Board of Directors and Director |
| Ms. Mei Sha | Deputy Gen. Mang. |
| Ms. Shuang Ying Wei | Deputy Gen. Mang. |
| Mr. Hang Zhou | Deputy Gen. Mang. |
| Ms. Bo Yong Liu | Chief Accountant, Deputy Gen. Mang. and Director |
| Haiying Xu | Director and Gen. Mang. |
| Qiang Xiao | Deputy Gen. Mang. |
| Mr. Guoren Lin | Director and Gen. Mang. |
Exchange: SHG
Country: CN
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 310 |
| Price-to-Book MRQ: | 2.2657 |
| Price-to-Sales TTM: | 0.7272 |
| IPO Date: | 1990-02-01 |
| Fiscal Year End: | December |
| Full Time Employees: | 11059 |